Posted on October 27, 2020 by Sitemaster
New data on this topic — from a Phase II/III clinical trial — have just been presented at the virtual annual meeting of the American Society for Radiation Oncology (ASTRO). Basically, the data from this study by Sahgal et al. indicated that 24 Gy (in two 12 Gy doses) of stereotactic body radiation therapy (SBRT) was more effective in the elimination of spinal pain in patients with metastatic cancer as compared to 20 Gy (in five 4 Gy doses) of conventional, external beam radiation therapy (EBRT).
… READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, EBRT, metastatic, pain, radiation, SBRT, spine | 3 Comments »
Posted on August 2, 2019 by Sitemaster
In 2011, the American Society for Radiation Oncology (ASTRO) issued a consensus statement as part of its “Choosing Wisely” campaign that found that 30 Gy in 10 fractions (treatments), 20 Gy in 5 fractions, and 8 Gy in 1 fraction all gave equivalent pain relief. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, pain, radiotherapy, relief | 7 Comments »
Posted on January 10, 2018 by Sitemaster
A newly published paper in The Lancet Oncology has provided early data from the LATITUDE trial on patient-reported outcomes (PROs) and health-related quality of life (HRQoL) for men with newly diagnosed, high-risk, metastatic, castration-naive prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse, effect, latitude, life, pain, quality, risk, trial | Leave a comment »
Posted on September 2, 2016 by Sitemaster
TAPS stands for “taxane acute pain syndrome”. It is a recognized side effect of treatment with taxanes like docetaxel and it is usually characterized by muscular pain (myalgia) and joint pain (arthralgia) that starts about 24 to 48 hours after taxane treatment and then lasts for up to about 7 days. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: chemotherapy, pain, TAPS, taxane, Treatment | 9 Comments »
Posted on June 17, 2015 by Sitemaster
An interesting paper that we managed to miss at the recent annual meeting of the American Society of Clinical Oncology (ASCO) provided the results of a large, randomized clinical trial of the use of zoledronic acid, carried out by the Cancer and Leukemia Group B cooperative trial group. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: acid, bone-related, events, fractures, pain, Prevention, skeletal, zoledronic | Leave a comment »
Posted on May 2, 2015 by Sitemaster
According to a newly published paper in the journal Pain, the presence of a particular genetic marker in cancer cells may be a key factor in risk for cancer-related pain. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gene, pain, TMPRSS2 | Leave a comment »
Posted on January 2, 2015 by Sitemaster
A small, randomized, pilot study has shown that music (along with some lidocaine) reduces the anxiety, pain, and dissatisfaction of men having a TRUS-guided biopsy compared to the lidocaine alone. … READ MORE …
Filed under: Diagnosis | Tagged: anxiety, biopsy, music, pain, satisfaction | 4 Comments »
Posted on June 13, 2014 by Sitemaster
It comes as no surprise that there is some urethral “discomfort” experienced by patients with an indwelling urethral catheter after a radical prostatectomy (regardless of the type of surgery), and that for some patients there can be a degree of significant penile pain until the catheter is removed (usually within about 8 to 10 days). … READ MORE
Filed under: Management, Treatment | Tagged: bupivacaine, pain, penile, post-surgery, urethral | 15 Comments »
Posted on November 21, 2013 by Sitemaster
A newly published paper by a team of Italian researchers has added a wrinkle to the critical questions about the most effective current and future forms of sequential therapy for men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, chemotherapy, docetaxel, mCRPC, metastatic, pain, palliation, radiopharmaceutical, radium, samarium, strontium | Leave a comment »
Posted on October 9, 2013 by Sitemaster
Data published in 2005 and later have clearly shown that — for most patients — single-fraction radiation therapy (e.g., a single dose of 8 Gy) is better than multi-fraction radiation therapy (e.g., 30 Gy given over 10 treatments) for the treatment of bone pain consequent to metastatic cancer that has spread into the bones (in prostate cancer and other forms of cancer). … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: bone, fraction, metastatsis, multiple, pain, palliation, radiation, single | 3 Comments »
Posted on June 26, 2013 by Sitemaster
Back in the 1970s and 1980s, before the availability of the PSA test (with all its flaws and benefits), it used to be the case that pain was one of the commonest symptoms leading to a diagnosis of prostate cancer … because the majority of men only got diagnosed when they already had advanced, metastatic disease. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: analgesia, castration-resistant, mCRPC, metastatic, pain | 3 Comments »
Posted on October 23, 2012 by Sitemaster
According to a media release issued yesterday, The U. S. Food and Drug Administration has approved a form of MRI-guided, focused ultrasound therapy for the treatment of pain associated with metastatic cancer to bone. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, ExAblate, focused, metastases, pain, therapy, ultrasound | 2 Comments »
Posted on August 29, 2012 by Sitemaster
According to a new, systematic review of data from four independently conducted clinical trials, tamoxifen may be the most effective agent for the management of breast events induced by treatment with non-steroidal antiandrogens (e.g., bicalutamide) in men with prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: antiandrogen, breast, gynecomastia, pain, tamoxifen | 7 Comments »
Posted on January 13, 2012 by Sitemaster
A group of medical students and fellows at Duke University have shown that if you distract patients’ attention while they are having a prostate biopsy it can (at least to some extent) reduce the likelihood of patient reports of pain and anxiety associated with the procedure. … READ MORE …
Filed under: Diagnosis | Tagged: anxiety, Bach, biopsy, Brandenberg, pain | 10 Comments »
Posted on November 19, 2011 by Sitemaster
A new article on the OncologySTAT web site provides a summary of a presentation by Alain Pecking, MD, from the annual meeting of the International Society for Geriatric Oncology. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, metastasis, outcome, pain, radionuclide, strontium-89 | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 